Skip to main content
Nxera Pharma Co., Ltd. logo

Nxera Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4565 ISIN · JP3431300007 LEI · 2138004M62BFNJMR2Z82 T Manufacturing
Open in API
Filings indexed 113 across all filing types
Latest filing 2025-03-26 Regulatory Filings
Country JP Japan
Listing T 4565

About Nxera Pharma Co., Ltd.

https://www.nxera.life/

Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.

Recent filings

Filing Released Lang Actions
内部統制報告書－第35期(2024/01/01－2024/12/31)
Regulatory Filings
2025-03-26 Japanese
確認書
Regulatory Filings
2025-03-26 Japanese
有価証券報告書－第35期(2024/01/01－2024/12/31)
Annual Report
2025-03-26 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 98% confidence The document explicitly states in the cover page and throughout the text that it is an "有価証券届出書" (Securities Registration Statement) and specifically a "訂正有価証券届出書（参照）" (Corrected Securities Registration Statement (Reference)). This type of filing, which details the offering of securities (in this case, stock issuance related to an RSU plan), corresponds to the regulatory filings required under Japanese financial law, which are generally covered by the 'Securities Registration Statement' concept in global databases. Since the provided list of codes does not have a specific code for a Japanese Securities Registration Statement (which is distinct from a US 10-K or a general Earnings Release), the most appropriate classification is the general regulatory filing category, 'RNS' (Regulatory Filings), as it is a formal submission to the regulatory body (Kanto Local Finance Bureau Director). The document is comprehensive, detailing the offering terms, methods, and intended use of funds, confirming it is the filing itself, not just an announcement of a filing (RPA).
2025-02-14 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 95% confidence The document explicitly states in the cover page and throughout the text that it is a "有価証券届出書" (Securities Registration Statement) and specifically a "訂正有価証券届出書（参照）" (Amended Securities Registration Statement (Reference)). This type of filing, which details the terms of a securities offering (in this case, related to Restricted Stock Units or RSU issuance), is a core regulatory filing in Japan. Since the provided definitions do not have a specific code for a Japanese Securities Registration Statement (which is analogous to a US S-1 or similar offering document), the most appropriate classification based on the provided list is the general regulatory filing category, 'RNS' (Regulatory Filings), as it is a mandatory disclosure document filed with the regulatory authority (関東財務局長 - Kanto Local Finance Bureau Director). It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a simple announcement of a report (RPA).
2025-02-14 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 98% confidence The document is titled "訂正有価証券届出書（参照）" which translates to "Amended Securities Registration Statement (Reference)". It is filed with the Kanto Local Finance Bureau ("関東財務局長"). The content details the offering of new shares (普通株式) related to a Restricted Stock Unit (RSU) compensation plan for directors and executives. A Securities Registration Statement (有価証券届出書) is a mandatory filing in Japan for public offerings of securities, which aligns closely with the US SEC's Form S-1 or similar registration documents, but none of the provided codes perfectly match a general Japanese registration statement. However, the document describes a capital/financing activity (issuance of shares for compensation) and is a formal regulatory filing related to securities offering. Given the options: - 10-K is for Annual Reports. - ER is for Earnings Releases. - IR is for comprehensive Interim Reports. - CAP (Capital/Financing Update) covers fundraising and capital structure changes. Since this document explicitly details the issuance terms, price, and purpose of new shares being offered (even if internally via RSU conversion), it falls under the scope of capital/financing activities. While it is a specific type of registration statement, 'CAP' is the most appropriate category among the choices for a document detailing the mechanics and terms of a share issuance/capital change, especially when a direct equivalent like 'S-1' or 'Shelf Registration' is missing. It is not a simple announcement (RPA/RNS) but the detailed filing itself.
2025-02-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.